BRPI0509256A - derivados de pirrolidina-3,4-dicarboxamida - Google Patents
derivados de pirrolidina-3,4-dicarboxamidaInfo
- Publication number
- BRPI0509256A BRPI0509256A BRPI0509256-6A BRPI0509256A BRPI0509256A BR PI0509256 A BRPI0509256 A BR PI0509256A BR PI0509256 A BRPI0509256 A BR PI0509256A BR PI0509256 A BRPI0509256 A BR PI0509256A
- Authority
- BR
- Brazil
- Prior art keywords
- pyrrolidine
- dicarboxamide derivatives
- dicarboxamide
- derivatives
- Prior art date
Links
- HEHBWXUFYYBHME-UHFFFAOYSA-N pyrrolidine-3,4-dicarboxamide Chemical class NC(=O)C1CNCC1C(N)=O HEHBWXUFYYBHME-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04101265.9 | 2004-03-26 | ||
| EP04101265 | 2004-03-26 | ||
| PCT/EP2005/002862 WO2005092881A1 (en) | 2004-03-26 | 2005-03-17 | Novel pyrrolidine-3,4-dicarboxamide derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0509256A true BRPI0509256A (pt) | 2007-09-11 |
| BRPI0509256B1 BRPI0509256B1 (pt) | 2019-02-12 |
Family
ID=34962445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0509256-6A BRPI0509256B1 (pt) | 2004-03-26 | 2005-03-17 | Derivados de pirrolidina-3,4-dicarboxamida que inibem o fator xa de coagulação |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7550487B2 (pt) |
| EP (1) | EP1732918B1 (pt) |
| JP (1) | JP4533428B2 (pt) |
| KR (1) | KR100847191B1 (pt) |
| CN (1) | CN1938294B (pt) |
| AR (1) | AR048589A1 (pt) |
| AT (1) | ATE414075T1 (pt) |
| AU (2) | AU2005225523B2 (pt) |
| BR (1) | BRPI0509256B1 (pt) |
| CA (1) | CA2560669C (pt) |
| DE (1) | DE602005010986D1 (pt) |
| DK (1) | DK1732918T3 (pt) |
| ES (1) | ES2314632T3 (pt) |
| HR (1) | HRP20090050T3 (pt) |
| IL (1) | IL177662A (pt) |
| MX (1) | MXPA06010827A (pt) |
| MY (1) | MY144101A (pt) |
| NO (1) | NO338531B1 (pt) |
| NZ (1) | NZ549395A (pt) |
| PL (1) | PL1732918T3 (pt) |
| PT (1) | PT1732918E (pt) |
| RU (1) | RU2379288C2 (pt) |
| SI (1) | SI1732918T1 (pt) |
| TW (1) | TWI295290B (pt) |
| WO (1) | WO2005092881A1 (pt) |
| ZA (1) | ZA200607606B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007005113A (es) * | 2004-11-03 | 2007-06-26 | Hoffmann La Roche | Nuevos derivados de dicarboxamida. |
| WO2006135054A1 (ja) | 2005-06-16 | 2006-12-21 | Dsm Ip Assets B.V. | 光学的立体造形用放射線硬化性液状樹脂組成物及びそれを硬化させて得られる光造形物 |
| WO2007053610A2 (en) * | 2005-11-01 | 2007-05-10 | The Regents Of The University Of California | Methods of treating atrial fibrillation wtih pirfenidone |
| AU2007338102A1 (en) * | 2006-12-22 | 2008-07-03 | F. Hoffmann-La Roche Ag | Processes for the preparation of (3R, 4R) -N- (4 -chlorophenyl) -1- (2, 2-difluoroethyl) -N' - [2-fluoro-4- (2-oxo-1 (2H) -pyridinyl) phenyl] -3, 4-pyrrolidinedicarboxamide |
| CA2685761A1 (en) * | 2007-05-10 | 2008-11-20 | F. Hoffmann-La Roche | New solid forms of fxa inhibitors |
| US8354444B2 (en) * | 2008-09-18 | 2013-01-15 | Hoffmann-La Roche Inc. | Substituted pyrrolidine-2-carboxamides |
| US20110152233A1 (en) * | 2009-12-18 | 2011-06-23 | Henner Knust | Pyrrolidine compounds |
| WO2012109996A1 (zh) | 2011-02-18 | 2012-08-23 | 上海璎黎科技有限公司 | 一种芳基糖苷类化合物及其制备方法和应用 |
| CN115666553A (zh) * | 2020-05-27 | 2023-01-31 | 轴向治疗公司 | Tlr2调节剂化合物及其药物组合物和用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999065867A1 (en) | 1998-06-17 | 1999-12-23 | Du Pont Pharmaceuticals Company | Cyclic hydroxamic acids as metalloproteinase inhibitors |
| CA2374820A1 (en) * | 1999-05-24 | 2000-11-30 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
| US6410733B1 (en) | 2000-09-11 | 2002-06-25 | Genentech, Inc. | Amidine inhibitors of serine proteases |
| US7030141B2 (en) | 2001-11-29 | 2006-04-18 | Christopher Franklin Bigge | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| US7205318B2 (en) * | 2003-03-18 | 2007-04-17 | Bristol-Myers Squibb Company | Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors |
| MX2007005113A (es) | 2004-11-03 | 2007-06-26 | Hoffmann La Roche | Nuevos derivados de dicarboxamida. |
| US7361672B2 (en) | 2004-12-23 | 2008-04-22 | Hoffmann-La Roche Inc. | Heteroarylacetamide inhibitors of factor Xa |
| US7820699B2 (en) | 2005-04-27 | 2010-10-26 | Hoffmann-La Roche Inc. | Cyclic amines |
| EP1907388A1 (en) | 2005-07-15 | 2008-04-09 | F. Hoffmann-Roche AG | Novel heteroaryl fused cyclic amines |
| US7678917B2 (en) | 2005-09-01 | 2010-03-16 | Hoffman-La Roche Inc. | Factor Xa inhibitors |
| BRPI0618523A2 (pt) | 2005-11-11 | 2011-09-06 | Hoffmann La Roche | compostos de aminas cìclicas fundidas carbocìclicas, composições farmacêuticas e usos dos mesmos |
| EP1951717A1 (en) | 2005-11-16 | 2008-08-06 | F.Hoffmann-La Roche Ag | Novel pyrrolidine derivatives as inhibitors of coagulation factor xa |
| EP1847537A1 (en) | 2006-04-21 | 2007-10-24 | F. Hoffmann-La Roche Ag | Dicarboxamide derivatives |
-
2005
- 2005-03-09 US US11/076,162 patent/US7550487B2/en not_active Expired - Fee Related
- 2005-03-17 NZ NZ549395A patent/NZ549395A/en not_active IP Right Cessation
- 2005-03-17 HR HR20090050T patent/HRP20090050T3/xx unknown
- 2005-03-17 AU AU2005225523A patent/AU2005225523B2/en not_active Ceased
- 2005-03-17 MX MXPA06010827A patent/MXPA06010827A/es active IP Right Grant
- 2005-03-17 JP JP2007504314A patent/JP4533428B2/ja not_active Expired - Fee Related
- 2005-03-17 DE DE602005010986T patent/DE602005010986D1/de not_active Expired - Lifetime
- 2005-03-17 ES ES05716166T patent/ES2314632T3/es not_active Expired - Lifetime
- 2005-03-17 CA CA2560669A patent/CA2560669C/en not_active Expired - Fee Related
- 2005-03-17 AT AT05716166T patent/ATE414075T1/de active
- 2005-03-17 PL PL05716166T patent/PL1732918T3/pl unknown
- 2005-03-17 PT PT05716166T patent/PT1732918E/pt unknown
- 2005-03-17 CN CN2005800098333A patent/CN1938294B/zh not_active Expired - Fee Related
- 2005-03-17 SI SI200530524T patent/SI1732918T1/sl unknown
- 2005-03-17 EP EP05716166A patent/EP1732918B1/en not_active Expired - Lifetime
- 2005-03-17 BR BRPI0509256-6A patent/BRPI0509256B1/pt not_active IP Right Cessation
- 2005-03-17 DK DK05716166T patent/DK1732918T3/da active
- 2005-03-17 RU RU2006137661/04A patent/RU2379288C2/ru not_active IP Right Cessation
- 2005-03-17 KR KR1020067019740A patent/KR100847191B1/ko not_active Expired - Fee Related
- 2005-03-17 WO PCT/EP2005/002862 patent/WO2005092881A1/en not_active Ceased
- 2005-03-22 TW TW094108790A patent/TWI295290B/zh not_active IP Right Cessation
- 2005-03-23 AR ARP050101146A patent/AR048589A1/es not_active Application Discontinuation
- 2005-03-24 MY MYPI20051293A patent/MY144101A/en unknown
-
2006
- 2006-08-23 IL IL177662A patent/IL177662A/en active IP Right Grant
- 2006-09-11 ZA ZA200607606A patent/ZA200607606B/en unknown
- 2006-10-24 NO NO20064821A patent/NO338531B1/no not_active IP Right Cessation
-
2012
- 2012-01-13 AU AU2012200212A patent/AU2012200212A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1900034I1 (hu) | 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok | |
| ATE477257T1 (de) | Piperidinylamino-thienoä2,3-dü- pyrimidinverbindungen | |
| IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
| ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
| ATE540935T1 (de) | Chinazolinderivate | |
| MA28347A1 (fr) | Dérivés de quinoléine substitués | |
| DK1761541T3 (da) | Pyrrazolo-pyrimidin-derivater | |
| ATE553079T1 (de) | Heteroarylphenylharnstoffderivat | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| NL2000937A1 (nl) | Piperidinederivaten. | |
| ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
| NL2000336A1 (nl) | Spirocyclische derivaten. | |
| IL177662A0 (en) | Novel pyrrolidine-3,4-dicarboxamide derivatives | |
| ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
| DK1740574T3 (da) | 4-amino-5-cyanopyrimidinderivater | |
| EP1799223A4 (en) | ARYLTHIOBENZYLPIPERIDINE DERIVATIVES | |
| ES1058958Y (es) | Mastil perfeccionado. | |
| ES1061238Y (es) | Bisagra hidraulica perfeccionada. | |
| ES1057865Y (es) | Desatascador de desagues. | |
| ES1058527Y (es) | Biberon perfeccionado. | |
| ES1057143Y (es) | Bolso-mochila perfeccionado. | |
| ES1056712Y (es) | Columpio perfeccionado. | |
| ES1057126Y (es) | Pulidora-abrillantadora perfeccionada. | |
| ES1058535Y (es) | Balaustrada perfeccionada. | |
| FI20041628A0 (fi) | Kolmiulotteinen, optinen mittausjärjestelmä |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/02/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/02/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 16A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2622 DE 06-04-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |